Triple
T38560408
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pyrazinamide |
E928064
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antitubercular drug |
C30877
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antitubercular drug Context triple: [Pyrazinamide, instanceOf, antitubercular drug]
-
A.
antitubercular agent
chosen
An antitubercular agent is a drug used to prevent or treat infections caused by Mycobacterium tuberculosis by inhibiting its growth or killing the bacteria.
-
B.
rifamycin antibiotic
A rifamycin antibiotic is a bactericidal antimicrobial agent that inhibits bacterial DNA-dependent RNA polymerase, commonly used to treat mycobacterial infections such as tuberculosis and leprosy.
-
C.
antimalarial drug
An antimalarial drug is a pharmacological agent used to prevent or treat malaria by targeting and inhibiting the growth or survival of Plasmodium parasites within the human host.
-
D.
antimetabolite
An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
-
E.
macrolide antibiotic
A macrolide antibiotic is a class of antibacterial drugs characterized by a large lactone ring that inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f76eb8d1808190a588af29d8b266d6 |
completed | May 3, 2026, 3:50 p.m. |
Created at: May 3, 2026, 4:32 p.m.